Sales & Marketing News | pharmaphorum

News

Boost to Enhertu's prospects as FDA clears Roche diagnostic

Roche gets the first FDA approval for a diagnostic test for HER2-ultralow breast cancer, now on the label of AstraZeneca and Daiichi Sankyo's Enhertu.

News

CHMP backs Bavarian Nordic's chikungunya jab

Bavarian Nordic is likely just weeks away from bringing the second chikungunya vaccine to the EU, and the first approved for use in adolescents.

News

AstraZeneca abandons plan for £450m vaccine plant in UK

In a shock move, AstraZeneca has ditched its plan to invest £450m in a new vaccine manufacturing plant in the UK.

News

EMA experts will look again at Leqembi's safety data

It seems Eisai and Biogen have another hurdle to jump over in their bid to get EU approval for their Alzheimer's disease therapy Leqembi.

News

Vertex bags FDA okay for its non-opioid pain drug

Vertex gets FDA approval for its non-opioid pain drug suzetrigine, the first new class of pain medicine in the US in more than 20 years.

News

Medicare price negotiations 'will continue under Trump'

President Trump will continue Medicare drug pricing negotiation but intends to look for improvements to the scheme according to CMS.

Boost to Enhertu's prospects as FDA clears Roche diagnostic

CHMP backs Bavarian Nordic's chikungunya jab

AstraZeneca abandons plan for £450m vaccine plant in UK

EMA experts will look again at Leqembi's safety data

Vertex bags FDA okay for its non-opioid pain drug

Medicare price negotiations 'will continue under Trump'

AZ grabs FDA nod for Ultomiris in rare kidney disease IgAN

Discover a new era of healthcare panel engagement: Grounded ...

News

Editor's Picks